Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
University of Groningen
Groninga, HolandaPublikationen in Zusammenarbeit mit Forschern von University of Groningen (3)
2022
-
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
The Lancet, Vol. 399, Núm. 10319, pp. 61-116
2021
-
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports, Vol. 3, Núm. 3
2005
-
Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial
Journal of Hepatology, Vol. 43, Núm. 4, pp. 630-636